AQST logo

Aquestive Therapeutics, Inc. (AQST)

Profile

Full Name

Aquestive Therapeutics, Inc.

Ticker

NASDAQ: AQST

Exchange

NASDAQ

Sector

Healthcare

Industry

Specialty & Generic Drug Manufacturers

Country

United States

IPO

July 25, 2018

Indexes

Not included

Website

https://www.aquestive.com

Employees

142

Key Details

Price

$3.77(-1.57%)

Market cap

$375.96M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$57.56M(+13.80% YoY)

Annual EPS

-$0.51(-292.31% YoY)

PE ratio

-

Next earnings date

Nov 3, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $3.77
    AQST price is $3.77

    30-Day Relative Volume

    0.80
    AQST 30-day relative volume is 0.80

    Price Performance

    Price Most recent change

    -1.57%
    AQST price was down -1.57% on Aug 29, 2025

    Price YTD change

    +5.9%
    AQST price is up +5.9% since January 1st

    Price 1-year change

    -14.32%
    AQST price is down -14.32% year-on-year

    Price 3-year change

    +177.21%
    AQST price is up +177.21% over the past 3 years

    Price Range

    Price All-time high

    $20.70
    AQST price is currently -81.78% below its historical high of $20.70

    Price 3-year low

    $0.72
    AQST price is currently +423.61% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $375.96M
    AQST market capitalization is $375.96 million

    Market cap 3-year change

    +418.16%
    AQST market capitalization is up +418.16% over the past 3 years

    Market cap All-time high

    $516.07M
    AQST market capitalization is currently -27.15% below its historical high of $516.07 million

    Market cap sector rank

    60.45%
    AQST market capitalization is higher than 60.45% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +9.51%
    AQST shares outstanding is up +9.51% year-on-year

    Shares Outstanding 3-Year Change

    +86.92%
    AQST shares outstanding is up +86.92% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.43
    AQST beta is 1.43

    200-day SMA

    $3.38
    AQST price is currently +11.40% above its 200-day simple moving average

    50-day SMA

    $3.85
    AQST price is currently -2.16% below its 50-day simple moving average

    RSI

    43.92
    AQST 14-day relative strength index is 43.92

    Volume

    0.80
    AQST 30-day relative volume is 0.80

    ATR

    $0.22
    AQST average true range is $0.22

    10-day Historical Volatility

    46.55%
    AQST 10-day historical volatility is 46.55%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $57.56M
    AQST annual revenue is $57.56 million

    Revenue Analysts estimate

    $42.11M
    AQST annual revenue is currently +36.68% higher than the consensus analysts' forecast

    Revenue 1-year change

    +13.8%
    AQST annual revenue is up +13.8% year-on-year

    Revenue Sector rank

    63.21%
    AQST annual revenue is higher than 63.21% of companies in Healthcare sector

    EPS

    EPS

    -$0.51
    AQST annual earnings per share is -$0.51

    EPS Analysts estimate

    -$0.59
    AQST annual earnings per share is currently -13.56% lower than the consensus analysts' forecast

    EPS 1-year change

    -292.31%
    AQST annual earnings per share is down -292.31% year-on-year

    EPS Sector rank

    62.46%
    AQST annual earnings per share is higher than 62.46% of companies in Healthcare sector

    Profit

    Gross profit

    $39.69M
    AQST annual gross profit is $39.69 million

    Gross margin

    68.95%
    AQST annual gross profit margin is 68.95%

    Operating profit

    -$30.77M
    AQST annual operating income is -$30.77 million

    Operating margin

    -53.46%
    AQST annual operating profit margin is -53.46%

    Net income

    -$44.14M
    AQST annual net profit is -$44.14 million

    Net margin

    -76.68%
    AQST annual net profit margin is -76.68%

    Expenses

    Total expenses

    $88.33M
    AQST annual total expenses is $88.33 million

    Operating expenses

    $70.46M
    AQST annual total operating expenses is $70.46 million

    Cost of goods sold

    $17.87M
    AQST annual cost of goods sold is $17.87 million

    Selling, general & administrative expenses

    $50.18M
    AQST annual SGA is $50.18 million

    Depreciation and amortization

    $718.00K
    AQST annual depreciation & amortization is $718.00 thousand

    Interest expense

    $16.82M
    AQST annual interest expense is $16.82 million

    Income tax

    -$14.00K
    AQST annual income tax is -$14.00 thousand

    EBIT & EBITDA

    EBIT

    -$27.33M
    AQST annual earnings before interest & taxes is -$27.33 million

    EBITDA

    -$26.62M
    AQST annual EBITDA is -$26.62 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $101.42M
    AQST annual total assets is $101.42 million

    Non current assets

    $13.20M
    AQST annual long term assets is $13.20 million

    Current assets

    $88.22M
    AQST annual total current assets is $88.22 million

    Cash and cash equivalents

    $71.55M
    AQST annual cash & cash equivalents is $71.55 million

    Accounts receivable

    $4.92M
    AQST annual accounts receivable is $4.92 million

    Inventory

    $6.04M
    AQST annual inventory is $6.04 million

    Liabilities

    Total liabilities

    $161.58M
    AQST annual total liabilities is $161.58 million

    Long term liabilities

    $142.72M
    AQST annual total long term liabilities is $142.72 million

    Current liabilities

    $18.86M
    AQST annual total current liabilities is $18.86 million

    Accounts payable

    $10.29M
    AQST annual accounts payable is $10.29 million

    Debt

    Total debt

    $121.94M
    AQST annual total debt is $121.94 million

    Total debt 1-year change

    +23.39%
    AQST annual total debt is up +23.39% year-on-year

    Long term debt

    $37.47M
    AQST annual long term debt is $37.47 million

    Short term debt

    $1.62M
    AQST annual short term debt is $1.62 million

    Equity & Capital

    Shareholders equity

    -$60.16M
    AQST annual stockholders equity is -$60.16 million

    Book value

    -$60.16M
    AQST annual book value is -$60.16 million

    Retained earnings

    -$363.21M
    AQST annual retained earnings is -$363.21 million

    Working capital

    $69.36M
    AQST annual working capital is $69.36 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$35.76M
    AQST annual cash flow from operations is -$35.76 million

    Cash from operations 1-year change

    -460.49%
    AQST annual cash flow from operations is down -460.49% year-on-year

    Cash from investing

    -$159.00K
    AQST annual cash flow from investing activities is -$159.00 thousand

    Cash from investing 1-year change

    +84.02%
    AQST annual cash flow from investing activities is up +84.02% year-on-year

    Cash from financing

    $83.59M
    AQST annual cash flow from financing activities is $83.59 million

    Cash from financing 1-year change

    +2003.47%
    AQST annual cash flow from financing activities is up +2003.47% year-on-year

    CAPEX

    CAPEX

    $159.00K
    AQST annual capital expenditures is $159.00 thousand

    CAPEX 1-year change

    -84.02%
    AQST annual capital expenditures is down -84.02% year-on-year

    Free Cash Flow

    Free cash flow

    -$35.92M
    AQST annual free cash flow is -$35.92 million

    Free cash flow 1-year change

    -387.02%
    AQST annual free cash flow is down -387.02% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    68.95%
    AQST annual gross profit margin is 68.95%

    Operating margin

    -53.46%
    AQST annual operating profit margin is -53.46%

    Net margin

    -76.68%
    AQST annual net profit margin is -76.68%

    ROA & ROE

    ROA

    -55.57%
    AQST annual return on assets is -55.57%

    ROE

    73.37%
    AQST annual return on equity is 73.37%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    AQST price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    AQST price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -5.18
    AQST price to book ratio is -5.18

    PB ratio Sector rank

    6.07%
    AQST price to book ratio is higher than 6.07% of companies in Healthcare sector

    PS Ratio

    PS ratio

    8.52
    AQST price to sales ratio is 8.52

    PS ratio Sector rank

    70.43%
    AQST price to sales ratio is higher than 70.43% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $441.68M
    AQST enterprise value is $441.68 million

    Enterprise value Sector rank

    65.39%
    AQST enterprise value is higher than 65.39% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -9.30
    AQST EV/EBITDA is -9.30

    EV/EBITDA Sector rank

    13.53%
    AQST EV/EBITDA is higher than 13.53% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.68
    AQST annual current ratio is 4.68

    Quick ratio

    4.36
    AQST annual quick ratio is 4.36

    Leverage

    Debt to equity

    -0.54
    AQST annual debt to equity ratio is -0.54

    Interest coverage ratio

    -1.63
    AQST annual interest coverage ratio is -1.63

    Risk & Stability

    Piotroski F-Score

    1
    AQST piotroski f-score is 1

    Altman Z-Score

    -3.12
    AQST altman z-score is -3.12

    Analyst ratings

    Recent major analysts updates

    Jun 17, 25 HC Wainwright & Co.
    Buy
    May 15, 25 HC Wainwright & Co.
    Buy
    Apr 2, 25 HC Wainwright & Co.
    Buy
    Mar 10, 25 HC Wainwright & Co.
    Buy
    Mar 7, 25 Lake Street
    Buy
    Dec 20, 24 HC Wainwright & Co.
    Buy
    Dec 17, 24 Cantor Fitzgerald
    Overweight
    Nov 11, 24 HC Wainwright & Co.
    Buy
    Nov 6, 24 HC Wainwright & Co.
    Buy
    Oct 25, 24 Leerink Partners
    Outperform

    Institutional Ownership

    Screeners with AQST included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Aquestive Therapeutics, Inc.?
    • Does Aquestive Therapeutics, Inc. pay dividends?
    • What sector is Aquestive Therapeutics, Inc. in?
    • What industry is Aquestive Therapeutics, Inc. in?
    • What country is Aquestive Therapeutics, Inc. based in?
    • When did Aquestive Therapeutics, Inc. go public?
    • Is Aquestive Therapeutics, Inc. in the S&P 500?
    • Is Aquestive Therapeutics, Inc. in the NASDAQ 100?
    • Is Aquestive Therapeutics, Inc. in the Dow Jones?
    • When was Aquestive Therapeutics, Inc.'s last earnings report?
    • When does Aquestive Therapeutics, Inc. report earnings?

    What is the ticker symbol for Aquestive Therapeutics, Inc.?

    The ticker symbol for Aquestive Therapeutics, Inc. is NASDAQ:AQST

    Does Aquestive Therapeutics, Inc. pay dividends?

    No, Aquestive Therapeutics, Inc. does not pay dividends

    What sector is Aquestive Therapeutics, Inc. in?

    Aquestive Therapeutics, Inc. is in the Healthcare sector

    What industry is Aquestive Therapeutics, Inc. in?

    Aquestive Therapeutics, Inc. is in the Specialty & Generic Drug Manufacturers industry

    What country is Aquestive Therapeutics, Inc. based in?

    Aquestive Therapeutics, Inc. is headquartered in United States

    When did Aquestive Therapeutics, Inc. go public?

    Aquestive Therapeutics, Inc.'s initial public offering (IPO) was on July 25, 2018

    Is Aquestive Therapeutics, Inc. in the S&P 500?

    No, Aquestive Therapeutics, Inc. is not included in the S&P 500 index

    Is Aquestive Therapeutics, Inc. in the NASDAQ 100?

    No, Aquestive Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Aquestive Therapeutics, Inc. in the Dow Jones?

    No, Aquestive Therapeutics, Inc. is not included in the Dow Jones index

    When was Aquestive Therapeutics, Inc.'s last earnings report?

    Aquestive Therapeutics, Inc.'s most recent earnings report was on August 11, 2025

    When does Aquestive Therapeutics, Inc. report earnings?

    The next expected earnings date for Aquestive Therapeutics, Inc. is November 3, 2025
    On this page